Prophylactic Platelet Transfusions are Not Superior to Supportive Care for Dengue Patients with Thrombocytopenia According to the World Health Organization, the incidence of dengue has increased 30-fold in the past 50 years, and over… April 12, 2017
Current Evidence Suggests that Non-invasive Procedures are Best to Treat Fetal and Neonatal Alloimmune Thrombocytopenia Fetal and neonatal alloimmune thrombocytopenia (FNAIT) occurs when maternal alloantibodies develop against fetal platelet antigens. FNAIT may cause severe bleeding… April 5, 2017
Large-Scale Iron Testing Feasible for Blood Centers Iron deficiency is a common problem among frequent blood donors. The Canadian Blood Services recently sought to identify donors at… March 29, 2017
Survival for Non-Trauma Patients Transfused with High Ratios of Plasma to Red Blood Cells Although numerous studies have reported improved survival for trauma patients transfused with higher ratios of fresh frozen plasma (FFP) compared… March 22, 2017
Liquid Plasma Acceptable for Severe Trauma Patients with Major Bleeding Recent studies have highlighted the importance of expeditious transfusion of plasma, platelets and red blood cells in a 1:1:1 ratio… March 16, 2017
New PLASMIC Scoring System to Help Diagnose Thrombotic Thrombocytopenic Purpura Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder caused by a lack of ADAMTS13 activity, which normally cleaves the… March 8, 2017
Administration of Fibrinogen Concentrate during Cardiac Surgery Does Not Significantly Reduce Blood Loss Since fibrinogen plays a key role in hemostasis and it is rapidly depleted during cardiac surgery, many cardiac surgeons give… March 1, 2017
Patients with Hematologic Cancers Have Lower Rates of Alloimmunization with RhD Over 20% of RhD-negative non-oncology patients exposed to RhD-positive red blood cells (RBCs) become alloimmunized to the RhD antigen. In… February 22, 2017
Zika-Positive Blood Donations Can Be Inactivated Using Pathogen Inactivation Technologies Emerging infections, such as the Zika virus (ZIKV), continue to surface due to global travel, migration, and the spread of… February 15, 2017
Transfusion Testing Strategies for Multiple Myeloma Patients Undergoing Anti-CD38 Therapy Anti-CD38 therapies such as daratumumab have increased survival time for patients with multiple myeloma. This novel therapy, however, interferes with… February 10, 2017
